Daisho Microline Holdings Limited Daisho Microline Holdings Limited (0567.HK), an investment holding company incorporated in Bermuda in 1989 and headquartered in Chai Wan, Hong Kong, engages primarily in the manufacture and trading of printed circuit boards; the trading of petroleum and energy products and related businesses; the manufacture and trading of printing and packaging products; and investments in funds. The company operates manufacturing facilities, including a printed circuit board plant exceeding 800,000 square feet in Huizhou, Guangdong Province, People's Republic of China, and conducts business across Hong Kong, Europe, the People's Republic of China, South Korea, North America, and other international markets, targeting electronics, energy, and packaging sectors. In recent developments, through its joint venture Noricap Fund, the company pursued the acquisition of interests in Full Smart Inc., a cryptocurrency platform operator, in 2024, and announced a capital injection into a target healthcare group in March 2025—valued at RMB160 million and focused on artificial intelligence-assisted health management platforms with expert consultations, chronic disease management, and corporate health services—furthering diversification into healthcare amid cooperation agreements with hospitals, clinics, insurance firms, and a Hong Kong-listed technology conglomerate subsidiary from late 2024 to early 2025.